Summary Squamous cell carcinoma (SCC) of the bronchus is considered to develop from preneoplastic 'dysplasia', but reports of sequential observation of this dysplasia-carcinoma sequence in humans are very few. We followed four dysplastic lesions found in the bronchi of three ex-chromate workers by bronchoscopy and biopsy and found that all of them progressed to SCC. Of the four lesions, three were severe dysplasias at the first biopsy which progressed to SCCs in 7-13 months. The last one was a slight dysplasia at the first biopsy and showed progression of the atypia to carcinoma in 6 years and 10 months. An immunohistochemical analysis of the chronological change in p53 protein expression in these lesions and in normal ciliated epithelium taken from the surroundings was conducted in each case. Overexpression of p53 protein was observed in two of the severe dysplasias and the one slight dysplasia, as well as their eventual SCCs. However, no such change was apparent in one case of severe dysplasia or its eventual SCC. Normal epithelium was consistently negative. Our results provide direct proof of the dysplasia-carcinoma sequence and suggest that alteration in the expression of p53 protein might be an important early event which persists. Therefore, the immunohistochemical detection of p53 overexpression in biopsy specimens of bronchial epithelium might be useful for evaluation of preneoplastic lesions in high-risk group individuals and for early diagnosis of bronchial cancer.
Dysplasia of the bronchial epithelium is considered to be a preneoplastic change that may evolve into carcinoma in situ and invasive SCC (Sozzi et al, 1992 ; Sundaresan et al, 1992; ; Bennet et al, 1993; Nuorva et al, 1993) . However, most studies of the dysplasia-carcinoma sequence have concentrated on histological examination or genetic and/or chromosomal abnormalities in the bronchial epithelia of post-mortem or post-operative lung cancer patients, and follow-up studies in vivo have been limited (Thiberville et al, 1995) . While a great deal of information points to an important role of p53 mutations in the development of bronchial carcinomas and gene alteration may occur in preneoplastic lesions (Vogelstein, 1990; Sozzi et al, 1992; Klein et al, 1993) , there has been no report of a dysplasia with p53 abnormality progressing sequentially to a carcinoma. The rarity of follow-up studies of the dysplasia-carcinoma sequence and of p53 abnormalities is related to the difficulty of finding preneoplastic lesions in the bronchi, because of their small size, location and difficulties in sampling.
Chromate workers are known to be a high-risk group for developing preneoplastic lesions and/or lung cancers and provide a good model for bronchial carcinogenesis (Pfeil, 1935; Baetjer, 1950; Hueper, 1966) . We have been following bronchial epithelial changes in ex-chromate workers using sputum cytology, bronchoscope and biopsy and have found several dysplastic lesions, some of which were considered likely to progress to SCCs (Nakagawa et al, 1984; Ishikawa et al, 1994) .
In this paper, we document the histological change from dysplasias to carcinomas over various periods and the results of immunohistochemical examination of p53 protein expression.
MATERIALS AND METHODS Subjects
Since October 1975, we have followed up a population of 84 men employed in a Tokyo factory that produced chromate compounds until August 1975. All of the 84 ex-workers underwent chest radiography and sputum cytology examinations in a local hospital every 6-12 months. On detection of abnormal radiological shadows, or atypical cells on sputum cytology, patients were admitted to our hospital. Further examinations, such as bronchoscopy with biopsy and computerized tomography (available since 1980), were then performed. In subjects with cancer, appropriate therapies including surgical intervention, irradiation and chemotherapy were applied. When premalignant bronchial lesions were found, re-examination by bronchoscopy with biopsy was performed regularly thereafter. Four lesions in three cases were found which progressed to SCC. When they were first found, the (WHO, 1975) . The other serial section was prepared for the immunohistochemical demonstration of p53 using the anti-p53 rabbit polyclonal antibody, RSP53 (Nichirei, Tokyo, Japan), that binds to both mutant and wild-type proteins. For the immunostaining, a kit for the streptavidin-biotin method was applied following the manufacturer's instructions (Histofine SAB-PO(M) Kit, Nichirei). The p53 reactivities were evaluated quantitatively and divided into two groups (-, negative; +, more than 1% of the cells positive) according to the estimated number of positive nuclei of either dysplastic or carcinoma cells.
Exposure to chromate compounds and cigarette smoke
The histories of exposure to chromate compounds, latent periods and smoking histories for the three cases are given in Table 1 . More details of chromium contents in the lungs of ex-chromate workers were described in an earlier paper (Ishikawa et al, 1994) .
RESULTS
Progressive changes in preneoplastic lesions observed during follow-up
Details of histological changes occurring in the four preneoplastic bronchial lesions in the three cases are summarized in Table 2 . For lesion A of case 1, the first biopsy specimen was taken from a bifurcation of the second bronchus in the left upper lobe. Microscopically, severe dysplasia was diagnosed. The second biopsy of the lesion, 3 months after the first, again revealed severe dysplasia. The last biopsy, 4 months after the second, SCC was found. The duration from the first diagnosis of dysplasia to the carcinoma appearance was 7 months. For lesion B of case 1, the tissue at the first biopsy was taken from a bifurcation of the second bronchus in the left lower lobe. Microscopically, severe dysplasia was evident ( Figure IA) . The second biopsy, taken after 8 months, showed SCC. For lesion C in case 2, the first biopsy specimen, taken from the second carina of the left lung, demonstrated severe dysplasia (Figure 2A) . Although a second biopsy 1 month after the first showed squamous metaplasia without atypia (Figure 3) , a third biopsy performed 1 year later demonstrated SCC, the total duration being 13 months. Lesion D in case 3, located at the third bronchus of right lower lobe, was diagnosed as slight dysplasia at the first biopsy ( Figure 4A) . A second biopsy, 2 years and 2 months after the first, showed moderate dysplasia ( Figure 5A ). demonstrated moderate dysplasia, severe dysplasia ( Figure 5B ), squamous metaplasia, slight dysplasia, slight dysplasia ( Figure  5C ), ciliated bronchial epithelium ( Figure 5D ) and finally SCC ( Figure 6 ). The duration from the first biopsy to carcinoma was 6 years and 10 months ( Table 3) . As none of the four carcinomas were surgically resected, their precise sizes could not be determined. However, from endoscopic findings, they were all less than 10 mm in diameter.
Immunohistochemical staining
The first biopsy specimen of each lesion and the related carcinoma and the ciliated normal bronchial epithelium were available for examination of p53 immunostaining. As shown in Table 3, p53 overexpression was detected in three of four dysplasias and in the related SCCs (Figures lB, 2B, 4B and 6B ). The average percentages of positive nuclei in dysplastic and tumour cells were as follows: 30% for slight dysplasia, more than 50% for severe dysplasia and 90% for SCC. In lesion A, however, both of the severe dysplasia and the related SCC showed negative staining. The ciliated normal bronchial epithelium in each case did not stain.
DISCUSSION
The first follow-up study of the dysplasia-carcinoma sequence was performed by Saccomanno et al (1974) , who examined sequential sputum cytology specimens of uranium miners and confirmed the presence of a sequence in many cases. No subsequent reports appeared until Ishikawa et al (1994) described bronchoscopy and biopsy findings for one lesion which progressed from severe dysplasia to carcinoma in the same population as examined here. The present four lesions confirm and extend the previous findings using the same observation methods.
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inalhesionmCiinn casep2and lesion Dmnas e3,de sqaous smetapaiae withou atypiaos vnnralclaeyuoa.eefud h Abnormalities of the p53 gene can be examined at the molecular level for invasive carcinomas of the lung, but with preneoplastic lesions the immunohistochemical approach is easier to apply (Sozzi et al, 1992; Sundaresan et al, 1992) . Nuorva et al (1993) examined p53 expression in preneoplastic bronchial lesions with various degrees of atypia and found that accumulation of p53 protein started at the stage of moderate or severe dysplasia. On the other hand, Bennett et al (1993) reported 6.7% and 29.5% p53 overexpression, even in squamous metaplasias and slight dysplasias respectively. Our study also revealed positive staining in one case with slight dysplasia. Therefore, p53 protein accumulation can be considered to be a very early event.
Until the present report, however, there has been no direct evidence that preneoplastic lesions with p53 overexpression can progress to p53-positive carcinomas. Therefore, our immunohistochemical finding of p53 overexpression in premalignant and associated malignant lesions of the bronchial mucosa is of particular interest, confirming a role for irreversible change in this tumorsuppressor gene (Greenblatt et al, 1994) . It provides further support for the conclusion of a dysplasia-carcinoma sequence in the development of squamous cell carcinomas in ex-chromate workers.
Lesions like squamous metaplasia or slight dysplasia of the bronchial epithelium are not infrequent, and many are reversible in nature (Tipton and Crocker, 1964) ; therefore, it is not practical to follow up all of them endoscopically. However, as indicated by the analysis of lesion D which had slight dysplasia and showed p53 overexpression, immunohistochemical assessment of this parameter in samples of slight dysplasia or squamous metaplasia obtained by biopsy may be a useful means to evaluate the likelihood of progression to a carcinoma. Those lesions showing p53 protein overexpression in more than 30% of the constituent cells are likely to possess a p53 gene mutation and to be irreversible, as indicated above.
